FindTrial
Sign In

To study skin hydration at 12 hours and 24 hours after applying lotion in babies.

Evaluation of moisturizing effect of Moisturex Baby Moisturizing Lotion in babies - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084280
Enrollment
34
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Moisturex Baby Moisturizing Lotion: At Day 1, the test sites (identified site on legs) will be cleaned, and babies will be acclimatized under controlled conditions of temperature (20-22

Sponsors

Sun Pharmaceutical Industries Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy babies with dry skin and/or normal skin determined clinically. 2. Between 3 months and 24 months of age. 3. Parents accepting not to use products with the same end benefit on babies during the entire study duration. 4. Parents cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures. 5. Parents having signed a Consent Form after being informed orally and in writing of all information concerning the study procedures and study objectives.

Exclusion criteria

Exclusion criteria: 1. Skin allergy antecedents or atopic subject. 2. Hypersensitivity to any cosmetic product, raw material. 3. Any clinically significant systemic or cutaneous disease, which may interfere with study procedures. 4. Babies on any medical treatment either systemic or topical which may interfere with the performance of the study (presently or in the past 1 month).

Design outcomes

Primary

MeasureTime frame
1. Skin Hydration using MoistureMeter SC after product application. Timepoint: 12 hour—

Secondary

MeasureTime frame
1.Skin Hydration using MoistureMeter SC at 24 hours after product application 2.TEWL measurements using VapoMeter at 12 hours and 24 hours after product application. 3. Clinical evaluation for skin tolerance (erythema and oedema), using Draize scale after product applicationTimepoint: 12 hour, 24 hour—

Countries

India

Contacts

Public ContactMs Preetha Paul

Sun Pharmaceuticals Industries Ltd

bhavesh.lalan@sunpharma.com7276309223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026